The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management R Yazdani, S Fekrvand, S Shahkarami, G Azizi, B Moazzami, ... Clinical Immunology 198, 19-30, 2019 | 94 | 2019 |
Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study S Hanaei, M Sadr, A Rezaei, S Shahkarami, NE Daryani, AZ Bidoki, ... Clinics and research in hepatology and gastroenterology 42 (3), 269-275, 2018 | 48 | 2018 |
The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunity E Salzer, S Zoghi, MG Kiss, F Kage, C Rashkova, S Stahnke, M Haimel, ... Science immunology 5 (49), eabc3979, 2020 | 45 | 2020 |
A novel VPS13B mutation in Cohen syndrome: a case report and review of literature S Momtazmanesh, E Rayzan, S Shahkarami, M Rohlfs, C Klein, N Rezaei BMC Medical Genetics 21, 1-6, 2020 | 33 | 2020 |
The first molecular genetics analysis of individuals suffering from nephropatic cystinosis in the Southwestern Iran S Shahkarami, H Galehdari, A Ahmadzadeh, M Babaahmadi, M Pedram Nefrologia 33 (3), 308-315, 2013 | 33 | 2013 |
Interleukin-4 and interleukin-10 gene polymorphisms in patients with inflammatory bowel disease N Ebrahimi Daryani, A Saghazadeh, S Moossavi, M Sadr, S Shahkarami, ... Immunological investigations 46 (7), 714-729, 2017 | 32 | 2017 |
Effect of class switch recombination defect on the phenotype of ataxia-telangiectasia patients P Amirifar, H Mozdarani, R Yazdani, F Kiaei, T Moeini Shad, ... Immunological Investigations 50 (2-3), 201-215, 2021 | 28 | 2021 |
Genetic mutations and immunological features of severe combined immunodeficiency patients in Iran Z Shahbazi, R Yazdani, S Shahkarami, S Shahbazi, M Hamid, ... Immunology letters 216, 70-78, 2019 | 17 | 2019 |
DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia S Younesian, S Shahkarami, P Ghaffari, S Alizadeh, R Mehrasa, ... Leukemia Research 61, 33-38, 2017 | 17 | 2017 |
Comprehensive assessment of respiratory complications in patients with common variable immunodeficiency B Moazzami, MAM Nasrabadi, H Abolhassani, P Olbrich, G Azizi, ... Annals of Allergy, Asthma & Immunology 124 (5), 505-511. e3, 2020 | 13 | 2020 |
The evaluation of neutropenia in common variable immune deficiency patients M Ghorbani, S Fekrvand, S Shahkarami, R Yazdani, M Sohani, ... Expert Review of Clinical Immunology 15 (11), 1225-1233, 2019 | 12 | 2019 |
Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease NE Daryani, M Sadr, S Moossavi, S Shahkarami, S Soltani, E Farhadi, ... Digestive Diseases and Sciences 60, 1389-1395, 2015 | 12 | 2015 |
Clinical and mutation description of the first iranian cohort of infantile inflammatory bowel disease: the iranian primary immunodeficiency registry (IPIDR) F Rahmani, E Rayzan, MR Rahmani, S Shahkarami, S Zoghi, A Rezaei, ... Immunological investigations 50 (4), 445-459, 2021 | 10 | 2021 |
Molecular characterization of Bruton's tyrosine kinase deficiency in 12 Iranian patients with presumed X-linked agammaglobulinemia. S Nasseri, R Sorouri, Z Pourpak, M Yeganeh, A Aghamohammadi, ... Journal of investigational allergology & clinical immunology 21 (7), 572-574, 2011 | 9 | 2011 |
Passive-specific immunotherapy with monoclonal antibodies for prostate cancer: A systematic review N Khalili, M Keshavarz-Fathi, S Shahkarami, A Hirbod-Mobarakeh, ... Journal of Oncology Pharmacy Practice 25 (4), 903-917, 2019 | 8 | 2019 |
Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL) S Shahkarami, R Mehrasa, S Younesian, M Yaghmaie, B Chahardouli, ... Annals of Hematology 97, 585-595, 2018 | 8 | 2018 |
Evaluation of expression of LRBA and CTLA-4 proteins in common variable immunodeficiency patients F Salami, S Fekrvand, R Yazdani, S Shahkarami, G Azizi, Y Bagheri, ... Immunological Investigations 51 (2), 381-394, 2022 | 7 | 2022 |
Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemia S Younesian, S Shahkarami, P Ghaffari, S Alizadeh, R Mehrasa, ... Annals of Hematology 98, 2719-2727, 2019 | 7 | 2019 |
Novel G6PC3 mutations in patients with congenital neutropenia: case reports and review of the literature SF Maroufi, Z Shaka, H Mojtabavi, M Sadeghalvad, E Rayzan, I Sedighi, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 6 | 2021 |
Evaluation of miR-210 expression in common variable immunodeficiency: patients with unsolved genetic defect F Babaha, R Yazdani, S Shahkarami, ZH Esfahani, H Abolhahassani, ... Allergologia et Immunopathologia 49 (2), 84-93, 2021 | 6 | 2021 |